1. Imbalance between MMP-2, 9 and TIMP-1 promote the invasion and metastasis of renal cell carcinoma via SKP2 signaling pathways
   Hongsheng Lu et al, 2014, Tumor Biology CrossRef
2. Altered Serum Levels of Matrix Metalloproteinase-2, -9 in Response to Electroconvulsive Therapy for Mood Disorders
   Chiyo Shibasaki et al, 2016, International Journal of Neuropsychopharmacology CrossRef
3. Matrix Metalloproteinases in Renal Diseases: A Critical Appraisal
   Oskar Zakiyanov et al, 2019, Kidney and Blood Pressure Research CrossRef
4. MiR‐622 acts as a tumor suppressor to induce cell apoptosis and inhibit metastasis in human prostate cancer
   Niloufar Targhazeh et al, 2021, Andrologia CrossRef
5. The effect of microRNA‐330 replacement on inhibition of growth and migration in renal cancer cells
   Jun Liu et al, 2022, Biotechnology and Applied Biochemistry CrossRef
6. Kidney Tubules — Scientific and Applied Value
   E. S Levitskaya et al, 2022, The Russian Archives of Internal Medicine CrossRef
7. Does the Immunohistochemical Expression of CD44, MMP-2, and MMP-9 in Association with the Histopathological Subtype of Renal Cell Carcinoma Affect the Survival of Patients with Renal Cancer?
   Magdalena Chrabańska et al, 2023, Cancers CrossRef
8. Paris Saponin VII Inhibits the Migration and Invasion in Human A549 Lung Cancer Cells
   Lei Fan et al, 2015, Phytotherapy Research CrossRef
9. Disease specific urinary biomarkers in the central nervous system
   Micah Duggins-Warf et al, 2023, Scientific Reports CrossRef
10. The urinary proteome and peptidome of renal cell carcinoma patients: a comparison of different techniques
    Francesca Raimondo et al, 2014, Expert Review of Proteomics CrossRef
11. Caspase‑10, matrix metalloproteinase‑9 and total laminin are correlated with the tumor malignancy of clear cell renal cell carcinoma
    Hua Qian et al, 2018, Oncology Letters CrossRef
12. Cellular uptake of proMMP-2:TIMP-2 complexes by the endocytic receptor megalin/LRP-2
    Manuel Johanns et al, 2017, Scientific Reports CrossRef
13. Urinary Biomarkers and Point-of-Care Urinalysis Devices for Early Diagnosis and Management of Disease: A Review
    Beatriz Sequeira-Antunes et al, 2023, Biomedicines CrossRef
14. Associations between matrix metalloproteinase, tissue inhibitor of metalloproteinase and collagen expression levels in the adjacent rectal tissue of colorectal carcinoma patients
    Katarina Dibdiakova et al, 2021, Molecular and Clinical Oncology CrossRef
15. Deguelin Impairs Cell Adhesion, Migration and Invasion of Human Lung Cancer Cells through the NF-κB Signaling Pathways
    Yung-Ting Hsiao et al, 2018, The American Journal of Chinese Medicine CrossRef
16. Higher Content but No Specific Activity in Gelatinase B (MMP-9) Compared with Gelatinase A (MMP-2) in Human Renal Carcinoma
    Grzegorz Młynarczyk et al, 2023, Cancers CrossRef
17. Substrate-zymography: a still worthwhile method for gelatinases analysis in biological samples
    Serena Ricci et al, 2015, Clinical Chemistry and Laboratory Medicine (CCLM) CrossRef
18. Urine matrix metalloproteinases and their extracellular inducer EMMPRIN in children with chronic kidney disease
    Kinga Musiał et al, 2015, Renal Failure CrossRef
19. The azetidine derivative, KHG26792 protects against ATP-induced activation of NFAT and MAPK pathways through P2X7 receptor in microglia
    Eun-A Kim et al, 2015, NeuroToxicology CrossRef
20. Dynamic urinary proteomic analysis in a Walker 256 intracerebral tumor model
    Linpei Zhang et al, 2019, Cancer Medicine CrossRef
21. CCR9/CCL25 expression in non-small cell lung cancer correlates with aggressive disease and mediates key steps of metastasis
    Pranav Gupta et al, 2014, Oncotarget CrossRef